Mr. Hyde
Natural health product licensed in Canada
- Licence holder
- Pro Supps USA, LLC
- NPN or DIN-HM
- 80072373
- Status
- Active licence
- Licence date
- 31 August 2016
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Citrus aurantium L.: La quantité ingérée de p-synéphrine doit être inférieure à 20 mg par dose journalière recommandée. L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants, aux femmes enceintes ou allaitantes et en cas de traitement anti-hypertenseur. La caféine et les sources de caféine ne sont pas autorisées dans les compléments alimentaires contenant Citrus aurantium L.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Acide bêta-aminopropionique Source : Beta-alanine | 2,500 milligramme | Not calculated |
| Glycine, N-(aminoiminométhyl)-N-méthyl-, monohydrochlorure Source : Chlorhydrate de créatine | 1,000 milligramme | Not calculated |
| 1,3,7-triméthylxanthine Source : Citrate de caféine | 400 milligramme | Not calculated |
| 1,3,7-triméthylxanthine Source : Caféine | 400 milligramme | Not calculated |
| L-Leucine Source : L-Leucine | 500 milligramme | Not calculated |
| Sulfate de (4-Aminobutyle)guanidinium Source : Sulfate d'agmatine | 500 milligramme | Not calculated |
| Malate de citrulline Source : Malate de citrulline | 500 milligramme | Not calculated |
| 1-(p-Hydroxyphényl)-2-aminoéthanol Source : Chlorhydrate de DL-Octopamine | 12.12 milligramme | Not calculated |
| Citrus aurantium Source : Pelure (fruit) Potency : 30 % Synephrine | 30 milligramme | Not calculated |
| Acide gamma-aminobutyrique Source : Acide 4-aminobutanoïque | 50 milligramme | Not calculated |
| 7,9-Dihydro-1,3,7,9-tétraméthyl-1H-purine-2,6,8(3H)-trione Source : Théacrine | 25 milligramme | Not calculated |
Non-medicinal ingredients
Sucralose, Bleu FD&C n° 1, Saveur de raisin, Lécithine, Acésulfame potassium, Saveur de goyave, Saveur de mangue, Saveur de cerise, Jaune FD&C No. 5, Maltodextrines résistantes, Saveur de punch aux fruits, Silice, Rouge FD&C N° 40, Saveur d'orange, Silicate de calcium, Acide DL-malique, Saveur de citron, Saveur de melon d'eau, Saveur de framboise, Acide citrique, Saveur de pomme verte
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 0.5 Mesures | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Caffeine helps to relieve fatigue, to promote endurance, and to enhance motor performance. Caffeine helps to promote alertness and wakefulness, and to enhance cognitive performance. Leucine is an essential amino acid involved in protein synthesis. Caffeine helps to temporarily increase basal metabolic rate/thermogenesis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
May cause paresthesia (pins and needles), headache, nausea, gastrointestinal discomfort, palpitations and diarrhea. Hypersensitivity/allergy is known to occur, in which case, discontinue use. May result in weight gain. May cause a flushing, tingling, or prickling sensation of the skin, in which case, reduce the dose. Caffeine has been shown to reduce blood flow to the heart muscle during exercise which might lead to cardiovascular complications such as chest pain, and irregular heartbeat even in healthy individuals. If those symptoms occur, discontinue use and consult a health care practitioner.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are following a low protein diet or are taking lithium, Levodopa, nitrates, or medication to treat erectile dysfunction. Consult a health care practitioner prior to use if you have a liver or kidney disorder, epilepsy, high blood pressure, glaucoma and/or detrusor instability (overactive bladder syndrome). Consumption with natural health products (e.g. bitter orange extract, synephrine, octopamine, ephedra), other drugs (e.g. ephedrine) which increase blood pressure, alcohol, other medications or health products with sedative properties is not recommended. Consumption with other caffeine-containing products (e.g. medications, coffee, tea, colas, cocoa, guarana, mate) is not recommended. This product is not intended as a substitute for sleep. Consult a health care practitioner if you are of childbearing age. Consult a health care practitioner prior to use if you have cardiovascular disease or hypertension, diabetes, prostate disorders, or are taking prescription medications. Ensure to drin enough fluid before, during, and after exercise.
- Contre-indications
Do not use if you are pregnant or breastfeeding. Do not use if you are taking blood pressure medications (either hypertensives or antihypertensives), thyroid medications, sympathomimetics, or monoamine oxidase inhibitors (MAOIs). Do not consume if you are taking decongestant-containing cold preparations (i.e. phenylephrine or pseudoephedrine), products containing ephedra or ephedrine, or other medications which increase blood pressure.
Source
Official Health Canada record, licence 80072373
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.